Lukas Biomedical Competitors and Similar CompaniesClear all
Lukas Biomedical's competitors and similar companies include Kymera Therapeutics, Synlogic, XBiotech and Adicet Bio.
 Lukas Biomedical Lukas Biomedical (路迦生醫股份有限公司) is a company that specializes in the research and the development of immunotherapy therapy for cancer treatment. |  Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. |  Synlogic Synlogic is a biopharmaceutical company that focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases. |  XBiotech XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
| ||
Founding Date | Founding Date 2013 | Founding Date 2017 | Founding Date 2013 | Founding Date 2005 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Watertown, US HQ Cambridge, US | Locations Cambridge, US HQ | Locations Austin, US HQ | Locations Redwood City, US HQ Boston, US |
Employees | Employees N/A | Employees 207 | Employees 7417% increase | Employees 8510% decrease | Employees 1438% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.1 b | Valuation ($) 17.1 m | Valuation ($) 234.4 m | Valuation ($) 116.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) NT$189.8m (FY, 2024) | Revenue (est.) $39.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods NT$61.6m (FY, 2024) | Cost of goods $39.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit NT$128.4m (FY, 2024) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income (NT$94.4m) (FY, 2024) | Net income ($311.4m) (FY, 2025) | Net income ($1m) (FY, 2025) | Net income ($45.5m) (FY, 2025) | Net income ($116.8m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 197m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 145.6m |
For sources of this data, please see the company profile
View Company Profiles
Kymera Therapeutics
HQ
Watertown, US
Employees
207
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View companySynlogic
HQ
Cambridge, US
Employees
74↑ 17% increase
Synlogic is a biopharmaceutical company that focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases.
View companyXBiotech
HQ
Austin, US
Employees
85↓ 10% decrease
XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
View company
Adicet Bio
HQ
Redwood City, US
Employees
143↑ 8% increase
Adicet Bio is a biotechnology company that develops therapies for cancer diseases.
View company